Try our Chrome extension
Easily add the current web-page from your browser directly into your changedetection.io tool, more great features coming soon!Changedetection.io needs your support!
You can help us by supporting changedetection.io on these platforms;
- Rate us at AlternativeTo.net
- Star us on GitHub
- Follow us at Twitter/X
- Check us out on LinkedIn
- And tell your friends and colleagues :)
The more popular changedetection.io is, the more time we can dedicate to adding amazing features!
Many thanks :)
changedetection.io team
Not yet seconds ago
False
Not yet seconds ago
2 hours ago
Pro-tip: Highlight text to add to ignore filters
* Home
* About Us
* Team
* Portfolio
* News
* Investors
* Fellowship
* Contact
Created with Sketch.
Bold investment in
the future of medicine
Representative Portfolio Companies”
A2 Biotherapeutics
Advanced biologics technology platform for next-gen immunotherapies
Affini-T Therapeutics
Unlocking the power of T cells against oncogenic driver mutations
Aktis Oncology
Discovering and developing a novel class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers
Allogene Therapeutics
Allogeneic CAR T (AlloCAR T ™) therapies for cancer
(NASDAQ: ALLO)
Alterome Therapeutics
Developing alteration-specific targeted therapies for the treatment of cancer
Asklepios BioPharmaceutical
Focused on discovering, developing and manufacturing next-generation, transformative TCR therapies targeting neoantigens in solid cancers
Acquired by Bayer in 2020
Avalyn Pharma
Developing targeted inhalation therapies for life-threatening pulmonary diseases
Candid Therapeutics
Developing potentially transformative drugs to address autoimmune diseases
Capstan Therapeutics
Developing therapeutics to reprogram immune cells for a broad range of diseases
Centessa Pharmaceuticals
A novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly validated programs
(NASDAQ: CNTA)
Dyne Therapeutics
Developing life-transforming therapies for patients with serious muscle diseases
(NASDAQ: DYN)
Halda Therapeutics
Developing a novel class of cancer therapies called RIPTACTM (Regulated Induced Proximity Targeting Chimeras) therapeutics
IconOVir Bio
Pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer
InduPro
Developing novel therapeutics based on identification and manipulation of protein pairings
Kronos Bio
Pursuing therapies against some of the most intractable cancer targets
(NASDAQ: KRON)
Kyverna Therapeutics
Developing cell therapies to treat autoimmune diseases
(NASDAQ: KYTX)
LB Pharmaceuticals
Developing innovative therapies for neuropsychiatric diseases, including schizophrenia
Neogene Therapeutics
Personalized T cell therapies to treat cancer
Acquired by AstraZeneca in 2023
Peloton Therapeutics
Advancing first-in-class small molecule therapies
Acquired by Merck in 2019
Precision Medicine Group
Supporting biopharmaceutical clients through clinical development and commercialization
Protego Biopharma
Dedicated to finding novel solutions for protein misfolding diseases
Quanta Therapeutics
Pioneering complex-directed therapies to treat RAS-driven cancer types
ReCode Therapeutics
Targeting the underlying genetic cause of disease for underserved patients
Scorpion Therapeutics
Target Engaged: Broadening the reach and impact of precision medicine for oncology
Tectonic Therapeutic
Transforming the discovery of novel G-protein-coupled receptors (GPCR)-targeted therapies
Third Arc Bio
Developing multifunctional antibodies that are optimized for best-in-class T cell engagement across solid tumors and inflammatory & immunology (I&I) disease
Vigil Neuroscience
Harnessing the power of microglia for the treatment of neurodegenerative diseases
(NASDAQ: VIGL)
Volastra Therapeutics
Developing novel therapies for the prevention and treatment of metastatic cancer
*
*
Transforming biomedical innovations into therapies
Make a meaningful difference in patients’ lives
© 2025 Vida Ventures, LLC
* Home
* About Us
* Team
* Portfolio
* News
* Investors
* Fellowship
* Contact
Top
|
For now, Differences are performed on text, not graphically, only the latest screenshot is available.
Screenshot requires Playwright/WebDriver enabled